Bank of America Corporation : Below the upper bound
Entry price | Target | Stop-loss | Potential |
---|
$29.28 |
$26.7 |
$30.1 |
+8.81% |
---|
As long as the stock price has not broken through the resistance level at 29.45 USD, investors should expect the price to decline with the support at 26.60 USD as the main target.
Strengths● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● With a P/E ratio at 10.24 for the current year and 9.45 for next year, earnings multiples are highly attractive compared with competitors.
● For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
Weaknesses● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.